🇺🇸 FDA
Patent

US 6372778

Sulfonamide inhibitors of aspartyl protease

expired A61KA61K38/00A61P

Quick answer

US patent 6372778 (Sulfonamide inhibitors of aspartyl protease) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Apr 16 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/00, A61P, A61P31/12, A61P31/18